Skip to main content

News

Korea cuts by 75bp on signs of slowdown

The Bank of Korea on Monday slashed its key rate by 75 basis points in a surprise move to counter an economic slowdown. The central bank also broadened its collateral rules to include some mortgage-backed securities on signs of a liquidity shortage.

Markets plunge on recession fears

Confirmation of a sharp contraction in the UK economy and fears of a similarly grim outlook elsewhere sparked a global sell-off in equities and commodities on Friday.

Fed $2.7bn down on Bear, GSE sell-off continues

The value of the assets held on the Federal Reserve's books as collateral for its $29 billion loan to failed investment bank Bear Stearns fell by 9.2% over the third quarter, it emerged Thursday. Data also showed foreign central banks flight from Fannie…

Greenspan backs bailout, more regulation

Alan Greenspan, a former chairman of the Federal Reserve seen as a fierce advocate of free markets, on Thursday said he supported both the US Treasury's $700 billion bailout plan and greater regulation of the financial system.

King justifies re-capitalisation

With banking conditions at their direst since the beginning of First World War, the British Treasury had to re-capitalise the country's ailing banking sector, said Mervyn King, the governor of the Bank of England.

Canada cuts rates further

Canada's central bank cut its key interest rate by a quarter-point on Tuesday, saying the country's economy needs the stimulus to ward off the effects of a recession in the United States.

Russia in currency-swap clampdown

With rouble under increasing strain, the Central Bank of Russia has announced stringent new limits on the maximum amount of currency swaps that may be traded each day.

ING gets Dutch lifeline

ING, the biggest financial services firm in the Netherlands, has become the latest major financial institution to receive a capital injection from the government.

You need to sign in to use this feature. If you don’t have a Central Banking account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account

.